NCT07691281

Brief Summary

To develop and administer online surveys to cancer patients and their families across diverse regions within the EU to detect possible disparities in their access to mental health screening and psychological-cognitive support

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
5mo left

Started Jul 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress11%
Jul 2026Dec 2026

First Submitted

Initial submission to the registry

June 15, 2026

Completed
23 days until next milestone

First Posted

Study publicly available on registry

July 8, 2026

Completed
7 days until next milestone

Study Start

First participant enrolled

July 15, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

July 8, 2026

Status Verified

June 1, 2026

Enrollment Period

3 months

First QC Date

June 15, 2026

Last Update Submit

July 2, 2026

Conditions

Mental HealthCancer

Keywords

mental health disparitiescancer carepsychoncology

Outcome Measures

Primary Outcomes (1)

  • Disparities in access to mental health

    Number of participants who experienced disparities in the access to and provision of mental health services, how frequently EU countries have encountered these disparities, and detection of the principal barriers and facilitators through thematic analysis

    through study completion, an average of 1 year

Study Arms (5)

adult cancer patients

Individuals aged 18 years or older at all cancer stages, who have been diagnosed with cancer, are currently undergoing treatment or have survived cancer

Caregivers of adult cancer patients

individuals that are aged 18 or older who currently provide, or have provided, care, psychosocial and physical support for an adult cancer patient

Paediatric cancer patients

Pediatric cancer patients 12-17 years, responding on behalf of themselves

caregivers of pediatric cancer patients (0-11y)

Family members and caregivers of patients between 0-11 years old, responding on behalf of their child and themselves

caregivers of pediatric cancer patients (12+ y)

Family members and caregivers of patients between 12-17 years old responding only on behalf of themselves

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Cancer patients (both adult and paediatric) and their family members\\caregivers living in EU.

You may qualify if:

  • residence in EU
  • internet access
  • access to a technological device for survey participation
  • individuals at all cancer stages who have been diagnosed with cancer, are currently undergoing treatment or have survived cancer
  • ability to understand and the willingness to sign a written informed consent document
  • residence in EU
  • internet access
  • access to a technological device for survey participation
  • individuals that are aged 18 or older who currently provide, or have provided, care, psychosocial and physical support for a cancer patient in the EU
  • ability to understand and the willingness to sign a written informed consent document

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

European Institute of Oncology, Milan

Milan, Mi, 20141, Italy

Location

MeSH Terms

Conditions

Psychological Well-BeingNeoplasms

Condition Hierarchy (Ancestors)

Personal SatisfactionBehavior

Study Officials

  • Gabriella Pravettoni, PhD

    European Institute of Oncology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gabriella Pravettoni, PhD

CONTACT

+39 0257489207Gabriella.Pravettoni@ieo.it

Ilaria Durosini, PhD

CONTACT

+39 0257489207ilaria.durosini@ieo.it

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2026

First Posted

July 8, 2026

Study Start

July 15, 2026

Primary Completion (Estimated)

October 15, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

July 8, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations

IT(1)